image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Updates

Advanced Medical Solutions

October 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • AMS
  • Price:
  • 127.75p
Sales up by £2m or 7% to £29.4m in H1 are certainly not to be sniffed at given the margins that AMS are making. Operating profit was ahead by £0.7m to £7.25m with the drop through from the revenue growth at 35% despite further investment in its US sales team to support its partners. Pretax profits were ahead 18% to £7.3m helped by lower interest. Eps was up 13%  to 2.9p.Much of the revenue growth was driven by LiquiBand, the tissue adhesive, which has pushed up the branded direct business by 27% to £4.1m. Sales of LiquiBand were c.£3.9m with US sales growing 51% to £1.3m as it continued to take market share from J&J’s Dermabond in the hospital sector (share has risen to ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Advanced Medical Solutions - Healthy signs for AMS (July 2014)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW